Robert H. Lurie Comprehensive Cancer Center — Chicago, Illinois

Robert H. Lurie Comprehensive Cancer Center is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

Robert H. Lurie Comprehensive Cancer Center has participated in 14 clinical trials with 1 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic, Advanced BRAF Mutant Melanoma.

Sponsors: Celgene, Abramson Cancer Center at Penn Medicine, Eisai Inc..

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Robert H. Lurie Comprehensive Cancer Center?

Robert H. Lurie Comprehensive Cancer Center has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Robert H. Lurie Comprehensive Cancer Center conducted?

Robert H. Lurie Comprehensive Cancer Center has 14 clinical trials on record, with 1 currently active. Their work covers Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic, Advanced BRAF Mutant Melanoma.

Is Robert H. Lurie Comprehensive Cancer Center accredited by Crixeo Health?

Yes — Robert H. Lurie Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Robert H. Lurie Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.